🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

642 results for “Pharma Mar S.A.” Clear

  1. OCTREOTIDE ACETATE, Paltusotine tablets

    Pharma Mar S.A.

    Carcinoid Syndrome

    phase 2 small molecule active

    1 trial

  2. ONO-4578, ONO-4578, BEVACIZUMAB, ONO-4578, CALCIUM FOLINATE, OXALIPLATIN, OPDIVO 10 mg/mL concentrate for solution for infusion., FLUOROURACIL

    Pharma Mar S.A.

    PD-L1 positive advanced colorectal cancer

    phase 2 small molecule active

    1 trial

  3. Ocaliva 5 mg film-coated tablets

    Pharma Mar S.A.

    Primary biliary cholangitis

    phase 2 small molecule active

    1 trial

  4. Odronextamab, Odronextamab, Odronextamab

    Pharma Mar S.A.

    B-cell non-Hodgkin lymphoma (NHL)

    phase 2 small molecule active

    1 trial

  5. Open-label, safety, tolerability and proof of concept study to evaluate the use of ANXV (recombinant human Annexin A5 protein) in the treatment of patients with either Diabetic Retinopathy or recent onset Retinal Vein Occlusion

    Pharma Mar S.A.

    Diabetic Retinopathy, Retinal Vein Occlusion

    phase 2 other active

    1 trial

  6. PEMBROLIZUMAB, PM54

    Pharma Mar S.A.

    Advanced malignancies

    phase 2 small molecule active

    1 trial

  7. PLACEBO, BELTAVAC polymerized grass mix, BELTAVAC polymerized grass mix, -

    Pharma Mar S.A.

    allergic rhinoconjunctivitis caused due to exposure to pollen grasses

    phase 2 small molecule active

    1 trial

  8. PLACEBO, BELTAVAC polymerized grass mix, BELTAVAC polymerized grass mix, BELTAVAC polymerized grass mix, -

    Pharma Mar S.A.

    Allergic rhinoconjunctivitis caused due to exposure to pollen grasses

    phase 2 small molecule active

    1 trial

  9. PM14, IRINOTECAN

    Pharma Mar S.A.

    Patients with Selected Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

  10. Paltusotine tablets, Paltusotine tablets

    Pharma Mar S.A.

    Acromegaly

    phase 2 small molecule active

    1 trial

  11. Pariglasgene brecaparvovec

    Pharma Mar S.A.

    Glycogen storage disease type Ia

    phase 2 small molecule active

    1 trial

  12. Pemetrexed EVER Pharma 25 mg/ml concentrate for solution for infusion, Carboplatino Aurovitas 10 mg/ml concentrado para solución para perfusión EFG, Pemetrexed Accord 25 mg/ml concentrate for solution for infusion, Pemetrexed Glenmark 10 mg/ml solución para perfusión, Carboplatino Hikma 10 mg/ml soluzione per infusione, OMTX705, Pemetrexed Accord 25 mg/ml concentrate for solution for infusion, Carboplatino Teva 10 mg/ml Concentrado para solución para perfusión, Carboplatino Accord 10 mg/ml concentrado para

    Pharma Mar S.A.

    Advanced/Metastatic Non-squamous Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  13. Pemetrexed Fresenius Kabi 500 mg powder for concentrate for solution for infusion, Paclitaxel AqVida 6 mg/ml concentrate for solution for infusion, REGN7075, Cisplatinum Accord, 1 mg/ml, koncentrat do sporządzania roztworu do infuzji., LIBTAYO 350 mg concentrate for solution for infusion., Carboplatin Hikma 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung

    Pharma Mar S.A.

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  14. Phase 1/2A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients with Advanced Solid Tumors

    Pharma Mar S.A.

    advanced solid tumors

    phase 2 other active

    1 trial

  15. Phase I Study of PM534 Administered to Patients with Advanced Solid Tumors

    Pharma Mar S.A.

    Advanced Solid Tumors

    phase 2 other active

    1 trial

  16. Phase I Study of PM534 to Patients with Advanced Solid Tumors

    Pharma Mar S.A.

    Advances solid tumors

    phase 2 other active

    1 trial

  17. Phase I, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM14 Administered Intravenously to Patients with Advanced Solid Tumors

    Pharma Mar S.A.

    Advanced Solid Tumors

    phase 2 other active

    1 trial

  18. Pimavanserin Capsules 10 mg, Pimavanserin 34 mg Capsule, Pimavanserin 20 mg Capsule

    Pharma Mar S.A.

    Irritability associated with autistic disorder in children and adolescents with ASD

    phase 2 small molecule active

    1 trial

  19. Pirfenidone Solution for Inhalation

    Pharma Mar S.A.

    Progressive pulmonary fibrosis [PPF] Idiopathic pulmonary fibrosis [IPF]

    phase 2 small molecule active

    1 trial

  20. Pirfenidone Solution for Inhalation

    Pharma Mar S.A.

    Interstitial Lung Diseases (ILD), including but not limited to idiopathic pulmonary fibrosis (IPF)

    phase 2 small molecule active

    1 trial

  21. Pirfenidone Solution for Inhalation, Pirfenidone Solution for Inhalation, Placebo for AP01

    Pharma Mar S.A.

    Progressive Pulmonary Fibrosis

    phase 2 small molecule active

    1 trial

  22. Piromelatine (Neu-P11)

    Pharma Mar S.A.

    idiopathic (isolated) Rapid Eye Movement Behavior Disorder

    phase 2 small molecule active

    1 trial

  23. Placebo

    Pharma Mar S.A.

    Severe Alcohol-Associated Hepatitis

    phase 2 small molecule active

    1 trial

  24. Placebo 100 mg tablet, NMD670, Placebo 300 mg tablet, NMD670

    Pharma Mar S.A.

    Type 3 spinal muscular atrophy

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources